|
|
HP-010801 Vitamin D2, EP
CAS:50-14-6
Structure£º
FormularL: C28H44O
F.W.: 396.65
Use:
Specification£º
|
 |
|
HP-010802 25-OH-VD2
CAS: 21343-40-8
Structure:
Formular:C28H44O2
F.W.: 412.65
Use:
Specification£º
|
 |
|
HP-010803 Doxercalciferol
CAS: 54573-75-0
Structure: 1¦Á-HydroxyVitamin D2
Formular: C28H44O2
F.W.: 412.65
Use: For the treatment of secondary hyperparathyroidism
Specification:
|
 |
|
HP-010804 1¦Á,25-Dihydroxy Vitamin D2
CAS: 60133-18-8
Structure:
Formular: C28H44O3
F.W.: 428.65
Use:
Specification£º
|
 |
|
HP-010805 Paricalcitol, Zemplar
CAS: 131918-61-1
Structure: 19-nor-1,25-dihydroxyvitamin D2
Formular: C27H44O3
F.W.: 416.64
Use: For the treatment of secondary hyperparathyroidism
Specification:
|
 |
|
HP-010806 Calcipotriol, Calcipotriene, EP
CAS: 112965-21-6, 112828-00-9
Structure: 24-cyclopropyl-(1¦Á,3¦Â,5Z,7E,22E,24S)- 9,10-Secochola-5, 7, 10 (19), 22-tetraene-1, 3, 24-triol
Formular: C27H40O3
F.W.: 412.62
Use: Anti-psoriatic
Specification:
|
 |
|
HP-010807 Seocalcitol
CAS:134404-52-7
Structure£º 1alpha,25-Dihydroxy-26,27-dimethyl-24a-homo-
22,23,24,24a-tetradehydroVitamin D3
FormularL: C30H46O3
F.W.: 454.68
Use:
Specification£º
|
 |
|
HP-010808 Tisocalcitate
CAS: 156965-06-9
Structure:
Formular: C31H48O5
F.W.: 500.71
Use:
Specification£º
|
 |
|
HP-010809 Inecalcitol
CAS:163217-09-2
Structure: (7E)-19-nor-9,10-seco-14¦Â-cholesta-5,7-dien-
23-yne-1¦Á,3¦Â,25-triol
Formular: C26H40O3
F.W.: 400.59
Use:
Specification£º
|
 |
|
HP-010810 Elocalcitol
CAS: 199798-84-0
Structure:
Formular: C29H43FO2
F.W.: 442.65
Use:
Specification£º
|
 |
|
HP-010811 Vitamin D3, EP
CAS:67-97-0
Structure£º
FormularL: C27H44O
F.W.: 384.64
Use:
Specification£º
|
 |
|
HP-010812 Calcifediol
CAS: 63283-36-3
Structure: 25-hydroxy Vitamin D3
Formular: C27H44O2
F.W.: 400.64
Use:
Specification£º
|
 |
|
HP-010813 Alfacalcidol, EP
CAS:41294-56-8
Structure: 1¦Á-HydroxyVitamin D3
Formular: C27H44O2
F.W.: 400.64
Use: Calcium regulator, Osteoporosis
Specification:
|
 |
|
HP-010814 Calcitriol, EP
CAS: 32222-06-3
Structure: 1¦Á,25-DihydroxyVitamin D3
Formular: C27H44O3
F.W.: 416.65
Use: Calcium regulator, Anti-psoriatic
Specification:
|
 |
|
HP-010815 Secalciferol
CAS:55721-11-4
Structure: (24R)-24,25-DihydroxyVitamin D3
Formular: C27H44O3
F.W.: 416.64
Use: Anti-psoriatic
Specification£º
|
 |
|
HP-010816 Tacalcitol
CAS: 57333-96-7, 93129-94-3 (monohydrate)
Structure: 1,24(R)-Dihydroxyvitamin D3
Formular: C27H44O3
F.W.: 416.64
Use: Antipsoriasia
Specification:
|
 |
|
HP-010817 Falecalcitriol
CAS:83805-11-2
Structure£º
Formular: C27H38F6O3
F.W.: 524.58
Use:
Specification
|
 |
|
HP-010818 Eldecalcitol
CAS: 104121-92-8
Structure: 1¦Á,25-dihydroxy-2¦Â-(3-hydroxypropoxy)Vitamin D3, ED-71
Formular: C30H50O5
F.W.: 490.72
Use: Osteoporosis
Specification:
|
 |
|
HP-010819 Maxacalcitol
CAS:103909-75-7
Structure: 22-Oxacalcitriol
Formular: C26H42O4
F.W.: 418.61
Use: suppression of parathyroid hormone (PTH)
Specification£º
|
 |
|
HP-010820 Lexacalcitol
CAS:131875-08-6
Structure:
Formular: C29H48O4
F.W.: 460.69
Use:
Specification£º
|
 |
|
HP-010821 Atocalcitol
CAS: 302904-82-1
Structure:
Formular:C32H46O4
F.W.: 494.71
Use:
Specification£º
|
 |
|
|
